Zevra Therapeutics (ZVRA) Debt Ratio (2014 - 2025)

Zevra Therapeutics' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.22 for Q4 2025.

• Quarterly Debt Ratio fell 34.89% year-over-year to 0.22 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.22 (down 34.89% YoY) and the FY2025 annual result came in at 0.22, down 34.89% from the prior year.
• Debt Ratio was 0.22 for Q4 2025 at Zevra Therapeutics, down from 0.23 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.4 in Q2 2024 and bottomed at 0.01 in Q1 2021.
• A 5-year average of 0.25 and a median of 0.25 in 2023 frame the typical range for Debt Ratio.
• Peak annual rise in Debt Ratio reached 38.74% in 2025, while the deepest fall reached 41.37% in 2025.
• Zevra Therapeutics' Debt Ratio stood at 0.01 in 2021, then jumped by 1092.81% to 0.1 in 2022, then surged by 140.91% to 0.25 in 2023, then jumped by 34.61% to 0.33 in 2024, then sank by 34.89% to 0.22 in 2025.
• Business Quant data shows ZVRA's Debt Ratio at 0.22 in Q4 2025, 0.23 in Q3 2025, and 0.24 in Q2 2025.